Hermann Nabi, PhD, HDR, is a regular researcher in the Oncology division at CHU de Québec-Université Laval Research Center and Assistant Professor of Epidemiology at the Department of Social and Preventive Medicine at the Faculty of Medicine of Université Laval. Prior to joining the Center and Université Laval in 2016, Dr. Nabi headed the Research Department of Social and Human Sciences, Epidemiology, Public Health at the Institut National du Cancer(INCa) and was a regular researcher at l’Institut National de la Santé et de la Recherche Médicale(INSERM U.1018) in France.
His team’s work focuses on precision medicine, this emerging medical approach for disease prevention and treatment that takes into account individual differences in genes, environment and lifestyle for each person. With advances in genomics and the advent of new molecular biology technologies, precision medicine is attracting a lot of attention and has become an area of strong international competition. However, despite the large volume and unprecedented rate of gene or biomarker discoveries, relatively few have reached the bedside or contributed to improving the health of populations. This relative poor performance could be explained by the fact that only a small proportion (about 3%) of all published global research addresses issues related to the integration of genomics innovations into health and disease prevention. For this reason, the ultimate goal of Dr. Nabi’s team is to generate evidence to facilitate a successful and responsible integration of precision medicine innovations into health care and prevention, particularly for cancer.
To achieve this goal, his work is organized around three main objectives:
1) Characterize the mechanisms and organizational implications of the progressive adoption of innovations in precision medicine in oncology,
2) Evaluate the impact of diagnostic and therapeutic innovations in precision medicine on the quality of life and clinical outcomes of cancer patients and the effectiveness for the health system,
3) Develop and evaluate intervention methods to support the integration of innovations, which takes into account patients and populations’ preferences, economic, accessibility and impact issues, in a knowledge transfer perspective.
The originality of this research program lies in its interdisciplinary approach, which combines a variety of skills and methodological tools to answer questions that are at the interface of several scientific fields. This approach proposes a new way of approaching translational research (the transfer of discoveries from laboratory to bedside), through the use of concepts, models and methods the human and social sciences, epidemiology, public health, health services research and implementation science.
1050, Chemin Ste-Foy
J0-01
Québec, Qc
Canada G1S 4L8
- Fortier, PhilippeEmployee+1 418-525-4444, extension 42296philippe.fortier@crchudequebec.ulaval.ca
- Gbessemehlan, DorianeMaster studentdoriane.gbessemehlan@crchudequebec.ulaval.ca
- Haroun, OuerdiaMaster studentouerdia.haroun@crchudequebec.ulaval.ca
- Jura, Kinsley-MarlieEmployeekinsley-marlie.jura@crchudequebec.ulaval.ca
- Kazemali, CorneliaMaster studentHôpital Saint-Sacrement+1 418-525-4444, extension 84563diana-cornelia.kazemali@crchudequebec.ulaval.ca
1050 Chemin Ste-Foy
J0-12
Québec, Québec
Canada G1S 4L8 - Lapointe, JulieEmployeeHôpital Saint-Sacrement+1 418-525-4444, extension 82552+1 418-682-7949julie.lapointe@crchudequebec.ulaval.ca
1050, chemin Sainte-Foy
J0-11
Québec, Québec
Canada G1S 4L8 - Leclerc, LucasEmployeeHôpital Saint-Sacrement+1 418-525-4444, extension 82651lucas.leclerc.1@ulaval.calucas.leclerc@crchudequebec.ulaval.ca
1050 Chemin Ste-Foy
J0-12C
Québec, Qc
Canada G1S 4L8 - Mazloomi, SaharnazMaster studentsaharnaz.mazloomi@crchudequebec.ulaval.ca
- Mbuya-Bienge, CynthiaDoctoral studentHôpital Saint-Sacrement+1 418-525-4444, extension 84857cynthia.mbuya-bienge.1@ulaval.cacynthia.mbuya-bienge@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J1-14
Québec, QC
Canada G1S 4L8 - Mefou Tasong, Créscence JoëlleDoctoral studentcrescence-joelle.mefou-tasong@crchudequebec.ulaval.ca
- Mendel, HayleyEmployeeHôpital Saint-Sacrementhayley.mendel@crchudequebec.ulaval.ca
1050, chemin Sainte-Foy
J0-12
Québec, QC
Canada G1S 4L8 - Olivier Chevrier, GabrielleEmployeegabrielle.olivier-chevrier@crchudequebec.ulaval.ca
- Omeranovic, ArianMaster studentHôpital Saint-Sacrement+1 418-525-4444, extension 81932arian.omeranovic@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J0-12C
Québec, QC
Canada G1S 4L8 - Omeranovic, ArianEmployeeHôpital Saint-Sacrement+1 418-525-4444, extension 81932arian.omeranovic@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J0-12C
Québec, QC
Canada G1S 4L8 - Ouellet, JadeEmployeeHôpital Saint-Sacrement+1 418-525-4444, extension 87392jade.ouellet@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J0-09
Québec, QC
Canada G1S 4L8 - Raîche, CamilleMaster studentHôpital Saint-Sacrementcamille.raiche.1@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J0-12
Québec, QC
Canada G1S 4L8 - Raîche, CamilleEmployeeHôpital Saint-Sacrementcamille.raiche.1@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
J0-12
Québec, QC
Canada G1S 4L8 - Savard-Déry, FloreEmployeeflore.savard-dery@crchudequebec.ulaval.ca
Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening
Journal ArticleJ Pers Med, 13 (7), 2023.
Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian context
Journal ArticleHum Genet, 142 (7), 2023.
Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners' Knowledge and Attitudes
Journal ArticleGenes (Basel), 14 (3), 2023.
Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015
Journal ArticleCurr Oncol, 30 (2), 2023.
Scope of coverage of medical genetics and genomics in pre-clerkship programs of Canadian faculties of medicine: A curriculum analysis
Journal ArticleAm J Med Genet A, 191 (1), 2023.
Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol
Journal ArticleBMJ Open, 12 (12), 2022.
Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals
Journal ArticleGenet Med, 24 (11), 2022.
Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges
Journal ArticleCrit Rev Oncol Hematol, 178 , 2022.
Personalized Approaches for the Prevention and Treatment of Breast Cancer
Journal ArticleJ Pers Med, 12 (8), 2022.
Issues associated with a hereditary risk of cancer: Knowledge, attitudes and practices of nurses in oncology settings
Journal ArticleCan Oncol Nurs J, 32 (2), 2022.
Active projects
- Optimiser l’application des approches de médecine de précision dans la prévention et le traitement des cancers, from 2023-07-01 to 2026-06-30
- Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), from 2017-11-01 to 2024-03-31
- Personalized risk-stratified breast cancer follow-up care: a feasibility and acceptability study, from 2023-06-26 to 2026-06-30
- Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2023-10-27
- Vers des trajectoires de soins en cancer du sein personnalisées en fonction du risque et des besoins des patientes: une étude de faisabilité et d'acceptabilité, from 2023-04-01 to 2025-03-31
- What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2024-01-14
Recently finished projects
- Enjeux de l’intégration de la Médecine de Précision en Oncologie : mieux comprendre pour mieux agir (teMPO), from 2018-07-01 to 2022-06-30
- Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
- Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2023-03-01